Home > Education Hub > Infographic: The Pre-IND to Market Approval Roadmap in the U.S.

Infographic: The Pre-IND to Market Approval Roadmap in the U.S.

Publications

Category:

Regulatory

Published on:

July 20, 2021

Understanding the clinical, preclinical, and technical development requirements is crucial when designing an early development pathway.

Check out our latest infographic for tips and insight into this process from the Alira Health Regulatory team.

Download: The Pre-IND to Market Approval Roadmap in the U.S.

Infographic Download

Related news

Events July 20, 2021

Webinar Recap: Risk Management & Regulatory Submissions

Download Alira Health's Senior Vice President, Regulatory Affairs, Mary McNamara-Cullinane's webinar presentation, How to Implement Risk Management into Regulatory Submissions Using(...)

Multimedia April 29, 2021

Alira Health Webinar Replay: Trends and Challenges in US and EU Combination Product Landscapes

Rewatch this timely webinar with Alira Health’s Regulatory leadership team featuring key insights and advice for U.S. and EU companies as they map out their own regulatory pathways(...)

News February 2, 2021

We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System

We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.

Clinical Regulatory

News January 7, 2021

Alira Health Adds CMC Services through Acquisition of Chamow & Associates

We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)

Advanced Analytics Regulatory Research & Development

News November 20, 2020

Alira Health’s Ventures Portfolio Company, X-COR Therapeutics, Closes Initial $2.6M Funding Round

Alira Health congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.(...)

Publications November 1, 2020

Reduce Time to Market with Pre-IND Meetings

Did you know reducing time to market is one of the biggest challenges companies face when seeking FDA approval on their drug development plans and clinical trials?

MedTech Regulatory

News August 11, 2020

CMS Issues Proposed Rule to Cover ‘Breakthrough’ Medical Devices

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive(...)

Our locations around the globe

USA, Boston

1 Grant Street, Suite 400, Framingham, Boston,
MA 01702, USA
+1 (774) 777 5255

USA, North Carolina

1340 Environ Way, 3rd Floor,
Chapel Hill,
NC 27517, USA
+1 919-929-5015
+1 919-928-9320

USA, San Francisco

San Francisco,
CA 94108, USA
+1 (774) 777 5255

France, Paris

12 Rue Charlot
75003 Paris, France
+33 (0)9 72 16 55 57

Germany, Munich

Kurfürstenstraße 22
80801 Munich, Germany
+49 (89) 416 14 22-0

Italy, Verona

Via Germania 2
37136 Verona, Italy
+39 045 820 26 66
+39 045 820 58 75

Italy, Bologna

Galleria Guglielmo Marconi 2
(all’altezza di Via Guglielmo Marconi 29)
40122 Bologna, Italy

Italy, Milan

Via Carlo Ottavio
Cornaggia 10
20123 Milan, Italy

Spain, Barcelona

Carrer de Balmes, 206 – Ático 2 08006 Barcelona, Spain
+34 (0)93 737 65 70

UK, Milton Keynes

Fairbourne Drive,
Atterbury Lakes,
Milton Keynes,
MK10 9RG, United Kingdom
+44 (0)1908 488787

Switzerland, Geneva

Campus Biotech Innovation Park
Avenue de Sécheron 15
1202 Geneva, Switzerland
+41 (0)61 205 9669

Switzerland, Basel

Badenstrasse 3
4057 Basel, Switzerland
+41 (0)61 205 9669

Contact us